AQ Podcast | Mexico: Claudia Sheinbaum’s Moment - Americas Quarterly
2025-03-20 • Google News
Virios Therapeutics Llc (VIRI)
US$ 0.7590%
Price Chart
Key Statistics
Market Cap
$ 206.5K
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
257.91K
52W High
$ 8.32
52W Low
$ 1.62
Dividend Yield
0.00%
Beta
1.58
Technicals
50-Day MA
4.5051
200-Day MA
7.6906
52 Week High
8.3225
52 Week Low
1.62
About VIRI
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response.
Employees
4
Headquarters
Alpharetta, GA
CEO
Mr. Gregory Duncan
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg